Year: 2024

Gamm Lab Discoveries Culminate in FDA Approval of a Clinical Trial for the Treatment of Inherited Photoreceptor Diseases

BlueRock Therapeutics LP, a clinical stage cell therapy company and subsidiary of Bayer AG, today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for OpCT-001, an investigational induced pluripotent stem cell (iPSC)-based cell therapy for the treatment of primary photoreceptor diseases. Discoveries over the past …

Gamm lab Discoveries Culminate in FDA Approval of a Clinical Trial for the Treatment of Inherited Photoreceptor Diseases

  BlueRock Therapeutics LP, a clinical stage cell therapy company and subsidiary of Bayer AG, today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for OpCT-001, an investigational induced pluripotent stem cell (iPSC)-based cell therapy for the treatment of primary photoreceptor diseases. Discoveries over the …

MERI Research Committee member Andreas Velten wins SIGGRAPH’s 2024 Test of Time Award

Andreas Velten, PhD, Associate Professor of Biostatistics and Medical Informatics, has received a 2024 Test of Time award from SIGGRAPH, the international meeting on graphics research. The award, which was for Velten’s 2013 research paper titled Femto-Photography: Capturing and Visualizing the Propagation of Light, is given to authors of earlier SIGGRAPH meeting papers that have had …

McPherson ERI Director David Gamm on Wisconsin Public Radio’s The Larry Meiller Show

Prof. David Gamm, Director of the McPherson Eye Research Institute, recently appeared on Wisconsin Public Radio’s Larry Meiller Show to discuss the latest research on and treatments for macular degeneration, glaucoma, optic nerve damage, and to field questions from callers on eye health. You can hear the full broadcast here.

12th Annual Alice R. McPherson Lecture (2024)

12th Annual Alice R. McPherson Lecture Thursday, June 6th, 2024; Health Science Learning Center room 1306 Guest Speaker: Michael Dyer, PhD (St. Jude Children’s Research Hospital) Retinoblastoma: From Developmental Origins to Molecular Targeted Therapy

Wisconsin State Journal features story on latest Vision Gallery exhibition

The May 6th edition of the Wisconsin State Journal features an article on Sight Beyond Vision, the latest exhibition at the McPherson ERI’s Mandelbaum & Albert Family Vision Gallery! This show, which is a collaboration between MERI and Arts for All Wisconsin, brings together work by Wisconsin artists with low vision. You can read the full article on …

McPherson ERI Spring 2024 InSights is out!

The new issue of InSights includes an extended piece on iPSC-derived retinal cell therapeutics and their road to clinical trials; a look at a MERI member’s work to develop new methods to assess vision in dogs; a snapshot of four MERI awardees in the Department of Ophthalmology and Visual Sciences who are researching Retinitis Pigmentosa, Age-related Macular …

Congratulations to Timothy Gomez for his appointment to the Retina Research Foundation M.D. Matthews Professorship!

The McPherson Eye Research Institute is pleased to announce the appointment of Dr. Timothy Gomez to the RRF M.D. Matthews Professorship. Dr. Gomez, a professor in the UW–Madison Department of Neuroscience, researches visual sensory cell development and regeneration. The RRF M.D. Matthews Professorship was established by the Retina Research Foundation, founded by the McPherson ERI’s …

Congratulations to Bikash Pattnaik for his new role as the Retina Research Foundation Daniel M. Albert Chair!

Dr. Pattnaik is an Associate Professor in the Department of Pediatrics and Department of Ophthalmology and Visual Sciences. His research in pediatric blindness has resulted in significant progress in our understanding of the molecular mechanisms behind developmental and inherited blindness conditions. The Daniel M. Albert Chair, named after the founder of the McPherson ERI, was …

Join Our Mission

The McPherson ERI and the UW–Madison Department of Ophthalmology and Visual Sciences (DOVS) are in the process of hiring a faculty member with a research program in AMD! The position lists PhD, MD, or MD/PhD as qualifications and at least 50% of their effort must be related to AMD research. The tenure home would be in DOVS. …